Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) is having an interesting …
Teva, considered the world's largest generic drug maker, has been challenged by generic price declines. The three-session stock decline since the company reported earnings on Thursday has been its largest drop in history. Generic …
Inc. now owns 69,183 shares of the company's stock valued at $2,220,000 after …
HighPoint Advisor Group LLC raised its stake in Teva Pharmaceutical Industries …
Shares of Teva Pharmaceutical Industries (NYSE:TEVA) have finally put in a near-term low. The stock is jumping over 3.5% but more importantly, it has broken-out …
One stock is being blown off the books and one had a blow out earnings report. SolarEdge: https://www.zacks.com/stock/quote/SEDG?cid=CS-YOUTUBE-FT …
PODELL JEFFREY sold $225,400 worth of stock. For the quarter, shares have …
Just says after the company reported sluggish Q2 earnings, investors are continuing to ditch the stock amid reports that Teva is desperately trying to sell off assets. …
Zacks Rank & Estimate Revisions Teva is a Zacks Rank #5 (Strong Sell) stock. With the company reporting disappointing results and lowering its outlook, Teva has seen the Zacks Consensus Estimate for current-year earnings being revised …